← back to search

Kah‐Leong Lim

National University of Singapore · SG
Area of research
Neurology · Epidemiology
Research interest
Research focused on Parkin and Mitophagy, with related work in PINK1, Monoamine oxidase, Monoamine oxidase B. Notable publications include 'Reactive oxygen species trigger Parkin/PINK1 pathway–dependent mitophagy by inducing mitochondrial recruitment of Parkin', 'A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models', and 'Potassium channel dysfunction in human neuronal models of Angelman syndrome'.
h-index
citations
2,241
works
20
NIH funding
primary concept
email

Recent publications

Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models
Journal of Neurochemistry 2025cited by 7position: lastdoi
In situ dual-activated NIRF/PA carrier-free nanoprobe for diagnosis and treatment of Parkinson's disease
Biosensors and Bioelectronics 2025cited by 4position: middledoi
Seipin deficiency-induced lipid dysregulation leads to hypomyelination-associated cognitive deficits via compromising oligodendrocyte precursor cell differentiation
Cell Death and Disease 2024cited by 15position: middledoi
Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
International Journal of Molecular Sciences 2023cited by 27position: middledoi
Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
Antioxidants 2023cited by 16position: middledoi
From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
International Journal of Molecular Sciences 2023cited by 15position: lastdoi
Adipose transplantation improves olfactory function and neurogenesis via PKCα-involved lipid metabolism in Seipin Knockout mice
Stem Cell Research & Therapy 2023cited by 6position: middledoi
Linking Heat Shock Protein 70 and Parkin in Parkinson’s Disease
Molecular Neurobiology 2023cited by 3position: middledoi
Mitochondria targeting drugs for neurodegenerative diseases—Design, mechanism and application
Acta Pharmaceutica Sinica B 2022cited by 95position: middledoi
BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
Journal of Alzheimer s Disease 2022cited by 20position: lastdoi
Lewy Body–like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α‐Synuclein Mutations
Annals of Neurology 2021cited by 93position: middledoi
Activation of Autophagy Ameliorates Age-Related Neurogenesis Decline and Neurodysfunction in Adult Mice
Stem Cell Reviews and Reports 2021cited by 14position: middledoi
A Flexi‐PEGDA Upconversion Implant for Wireless Brain Photodynamic Therapy
Advanced Materials 2020cited by 93position: middledoi
Potassium channel dysfunction in human neuronal models of Angelman syndrome
Science 2019cited by 181position: middledoi
Visualization of Intra‐neuronal Motor Protein Transport through Upconversion Microscopy
Angewandte Chemie International Edition 2019cited by 68position: middledoi
PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1–Parkin-mediated mitophagy
Cell Research 2018cited by 179position: middledoi
The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson’s Disease
Parkinson s Disease 2018cited by 111position: middledoi
Reactive oxygen species trigger Parkin/PINK1 pathway–dependent mitophagy by inducing mitochondrial recruitment of Parkin
Journal of Biological Chemistry 2017cited by 235position: middledoi
Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
Cell Death and Disease 2017cited by 120position: middledoi
Parkin Regulation and Neurodegenerative Disorders
Frontiers in Aging Neuroscience 2016cited by 86position: lastdoi
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1
Nature Communications 2016cited by 85position: middledoi
Nutraceuticals in Parkinson’s Disease
NeuroMolecular Medicine 2016cited by 69position: lastdoi
A Small‐Molecule Probe for Selective Profiling and Imaging of Monoamine Oxidase B Activities in Models of Parkinson’s Disease
Angewandte Chemie International Edition 2015cited by 101position: middledoi
Mitochondrial dysfunction and Parkinson disease: a Parkin–AMPK alliance in neuroprotection
Annals of the New York Academy of Sciences 2015cited by 95position: lastdoi
A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models
Nature Communications 2014cited by 204position: middledoi
Endocytic Pathways Downregulate the L1-type Cell Adhesion Molecule Neuroglian to Promote Dendrite Pruning in Drosophila
Developmental Cell 2014cited by 93position: middledoi
DAMPs and neurodegeneration
Ageing Research Reviews 2014cited by 79position: lastdoi
Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry
Frontiers in Neurology 2013cited by 76position: firstdoi
AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in<i>Drosophila</i>Models of Parkinson's Disease
Journal of Neuroscience 2012cited by 171position: lastdoi
Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
Cancer Research 2012cited by 95position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Chengwu Zhang · National University of Singapore13 papers (2013–2025)Lin Li · Guangzhou Medical University6 papers (2014–2023)Eng‐King Tan · National University of Singapore5 papers (2012–2021)Chou Chai · National University of Singapore3 papers (2012–2020)Bin Xiao · Nanjing University of Chinese Medicine3 papers (2017–2021)Li Lu · Binghamton University3 papers (2021–2024)Wei‐Yi Ong · National University of Singapore3 papers (2020–2025)Liting Hang · National University of Singapore3 papers (2015–2016)Wulin Yang · Anhui Medical University2 papers (2023–2024)Yee Jie Yeap · Nanyang Technological University2 papers (2022–2023)Fengwei Yu · National University of Singapore2 papers (2012–2014)Weonjin Yu · Duke-NUS Medical School2 papers (2019–2021)Yanqiu Li · Capital Medical University2 papers (2023–2024)Changmin Yu · National University of Singapore2 papers (2023–2023)Alfred Xuyang Sun · Agency for Science, Technology and Research2 papers (2019–2021)Zhongting Zhao · Anhui Medical University2 papers (2023–2023) · 2 papers (2012–2016)Jing Yang · Nanjing University of Chinese Medicine2 papers (2023–2024)Qing Zhu · Shandong University2 papers (2014–2015)H. Shawn Je · National University of Singapore2 papers (2019–2021)